CS208475B2 - Method of making the hydrogencitrate of the alcalic met - Google Patents

Method of making the hydrogencitrate of the alcalic met Download PDF

Info

Publication number
CS208475B2
CS208475B2 CS783982A CS398278A CS208475B2 CS 208475 B2 CS208475 B2 CS 208475B2 CS 783982 A CS783982 A CS 783982A CS 398278 A CS398278 A CS 398278A CS 208475 B2 CS208475 B2 CS 208475B2
Authority
CS
Czechoslovakia
Prior art keywords
citric acid
weight
citrate
urine
ions
Prior art date
Application number
CS783982A
Other languages
Czech (cs)
English (en)
Inventor
Rolf Madaus
Werner Stumpf
Klaus Goerler
Alfonso C Beltran
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of CS208475B2 publication Critical patent/CS208475B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS783982A 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met CS208475B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2727304A DE2727304C2 (de) 1977-06-16 1977-06-16 Saures Alkalicitrat, dessen Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
CS208475B2 true CS208475B2 (en) 1981-09-15

Family

ID=6011690

Family Applications (1)

Application Number Title Priority Date Filing Date
CS783982A CS208475B2 (en) 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met

Country Status (26)

Country Link
US (1) US4820870A (ro)
JP (1) JPS545912A (ro)
AR (1) AR219109A1 (ro)
AU (1) AU519032B2 (ro)
BE (1) BE868089A (ro)
BG (1) BG41657A3 (ro)
CA (1) CA1133506A (ro)
CH (1) CH634813A5 (ro)
CS (1) CS208475B2 (ro)
DE (1) DE2727304C2 (ro)
DK (1) DK270578A (ro)
FR (1) FR2394513A1 (ro)
GB (1) GB1583840A (ro)
GR (1) GR64516B (ro)
HK (1) HK46481A (ro)
IL (1) IL54734A (ro)
IT (1) IT1214864B (ro)
MX (1) MX4999E (ro)
NL (1) NL174345C (ro)
PL (1) PL118528B1 (ro)
PT (1) PT68096A (ro)
RO (1) RO76941A (ro)
SE (1) SE438851B (ro)
SU (1) SU812167A3 (ro)
YU (1) YU41105B (ro)
ZA (1) ZA783409B (ro)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6393968A (ja) * 1986-10-06 1988-04-25 株式会社フジタ 地下立体駐車場
JPH02104870A (ja) * 1988-10-11 1990-04-17 Iwataro Moriyama 駐車装置
GB9221111D0 (en) * 1992-10-07 1992-11-18 Cerestar Holding Bv Process for the production of an alkali metal citrate
DE4328577C2 (de) * 1993-08-25 1997-09-11 Madaus Ag Alkalicitrate und deren Verwendung als Arzneimittel
ES2129146T3 (es) * 1994-03-23 1999-06-01 Madaus Ag Compuestos citratos alcalino-calcicos y su utilizacion como medicamentos.
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE4409948A1 (de) * 1994-03-23 1995-09-28 Madaus Ag Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
RU2238735C1 (ru) * 2003-05-29 2004-10-27 Семин Михаил Викторович Средство для литолиза мочевых камней и способ его получения
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
WO2018080986A1 (en) * 2016-10-27 2018-05-03 Seixas Mikelus Stefanie A Juice beverage for prevention and treatment of renal stones
PL238507B1 (pl) 2018-11-27 2021-08-30 Kozak Dariusz P H M Polcomm Wiertło z podwójnymi nacinakami
CN111116350A (zh) * 2019-12-28 2020-05-08 湖南九典制药股份有限公司 一种枸橼酸氢钾钠的制备方法
CN114404142B (zh) * 2022-02-23 2024-03-29 天津富勤科技股份有限公司 一种产生中性或弱酸性蒸汽的自发热眼罩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968843C (de) * 1953-11-29 1958-04-03 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von pharmakologisch wirksamen Magnesiumsalzen der Citronensaeure
DE1016251B (de) * 1955-01-22 1957-09-26 Adolf Christian Josef Opferman Verfahren zur Herstellung von zur Behandlung der Lungentuberkulose dienendem Monomagnesiumdicalciumcitrat
US3658969A (en) * 1969-11-14 1972-04-25 Codex Sa Pharmaceutical compositions useful in citric acid therapy

Also Published As

Publication number Publication date
ZA783409B (en) 1979-07-25
FR2394513B1 (ro) 1982-11-19
AR219109A1 (es) 1980-07-31
IL54734A0 (en) 1978-07-31
IT7824553A0 (it) 1978-06-14
AU3716278A (en) 1979-12-20
FR2394513A1 (fr) 1979-01-12
HK46481A (en) 1981-09-25
GB1583840A (en) 1981-02-04
NL174345C (nl) 1984-06-01
DE2727304C2 (de) 1982-12-02
SE438851B (sv) 1985-05-13
JPS545912A (en) 1979-01-17
IL54734A (en) 1982-09-30
YU41105B (en) 1986-12-31
BG41657A3 (en) 1987-07-15
DE2727304A1 (de) 1979-01-04
CA1133506A (en) 1982-10-12
YU142778A (en) 1982-10-31
DK270578A (da) 1978-12-17
BE868089A (fr) 1978-12-14
NL174345B (nl) 1984-01-02
IT1214864B (it) 1990-01-18
GR64516B (en) 1980-04-09
MX4999E (es) 1983-02-02
AU519032B2 (en) 1981-11-05
SU812167A3 (ru) 1981-03-07
PL207657A1 (pl) 1979-06-04
CH634813A5 (de) 1983-02-28
US4820870A (en) 1989-04-11
PT68096A (de) 1978-06-01
PL118528B1 (en) 1981-10-31
SE7806684L (sv) 1978-12-17
NL7805747A (nl) 1978-12-19
RO76941A (ro) 1981-06-22

Similar Documents

Publication Publication Date Title
CS208475B2 (en) Method of making the hydrogencitrate of the alcalic met
Prescott Pharmacokinetic drug interactions
KR100412219B1 (ko) 분자 요오드의 경구투여용 제약 조성물
US8759398B2 (en) Phosphorus binder composition for treatment of hyperphosphatemia
SK12692001A3 (sk) Zmesi valdecoxibu
JPH0261924B2 (ro)
US5006551A (en) Composition for destroying malignant tumors
FR2688405A1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
US20170312309A1 (en) Intradialytic administration of sodium thiosulfate
IE60713B1 (en) Use of athiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament
CA3009332A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
US4447455A (en) Oral urolithiasis remedy
JP2009526086A (ja) 燐酸過剰血による病気を治療する薬物及びその製造方法
US4400535A (en) Acidic alkali citrate and compositions for adjusting the pH of urine
JP6063939B2 (ja) Ｌ−ヒスチジンおよびその誘導体の新規用途
RU2101014C1 (ru) Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
US7855191B2 (en) Agent having a destructive effect on malignant tumors and method for the production thereof
Taraszka et al. Effect of dissolution rate of sulfamethazine from tablets on absorption and excretion of sulfamethazine
KR20130047262A (ko) 제어된 방출성의 아스코르빈산 함유 경구용 정제 조성물 및 그 분석방법
KR20210012919A (ko) 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
Noble et al. Indapamide in the stepped-care treatment of obese hypertensive patients
JP2019131589A (ja) ２型糖尿病またはその合併症を処置する組成物と合わせる、マグネシウムの経口投与のための組成物
JPH11255642A (ja) 骨組織傷害の予防又は処置のため及び骨構造要素の強化のための医薬品ならびに該医薬品の製法
Mukhopadhayay et al. Differential Impact of Organic Vanadium Compounds on Human Health: Deficiency States, Toxic Effects, and Potential Therapeutic Use
JPS5834445B2 (ja) 経口抵尿結石症剤